US · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at -0.34 against a street estimate of -0.17 — a miss of 100.0%.
Analysts rate Rockwell Medical Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $20.00.
| Fund | Stake |
|---|---|
| Vanguard Capital Management, LLC | 3.05% |
| Geode Capital Management, LLC | 0.90% |
| Renaissance Technologies Corp | 0.89% |
| Jane Street Group LLC | 0.61% |
| Vanguard Fiduciary Trust Co | 0.58% |
| Sontag Advisory LLC | 0.38% |
| BlackRock Inc | 0.36% |
| State Street Corp | 0.25% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Rockwell Medical Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.